Effect of oral vitamin B-12 with or without folic acid on cognitive function in older people with mild vitamin B-12 deficiency: A randomized, placebo-controlled trial
| Autor: | Simone J Eussen, Lisette C de Groot, Liesbeth W Joosten, Rubia J Bloo, Robert Clarke, Per M Ueland, Jörn Schneede, Henk J Blom, Willibrord H Hoefnagels, Wija A van Staveren |
|---|---|
| Předmět: |
Global Nutrition
impairment Wereldvoeding Nutrition and Dietetics elderly people folate-deficiency methylmalonic acid Cardiovascular diseases [NCEBP 14] Energy and redox metabolism [NCMLS 4] Effective Hospital Care [EBP 2] Medicine (miscellaneous) cobalamin deficiency Vascular medicine and diabetes [UMCN 2.2] Cognitive neurosciences [UMCN 3.2] depression supplementation Determinants of Health and Disease [EBP 1] plasma homocysteine serum VLAG dementia |
| Zdroj: | Scopus-Elsevier The American Journal of Clinical Nutrition, 84, 361-70 The American Journal of Clinical Nutrition, 84, 2, pp. 361-70 American Journal of Clinical Nutrition, 84(2), 361-370 American Journal of Clinical Nutrition 84 (2006) 2 |
| ISSN: | 0002-9165 |
| Popis: | Contains fulltext : 50233.pdf (Publisher’s version ) (Closed access) BACKGROUND: Vitamin B-12 deficiency is associated with cognitive impairment in older people. However, evidence from randomized trials of the effects of vitamin B-12 supplementation on cognitive function is limited and inconclusive. OBJECTIVE: The objective was to investigate whether daily supplementation with high doses of oral vitamin B-12 alone or in combination with folic acid has any beneficial effects on cognitive function in persons aged >/=70 y with mild vitamin B-12 deficiency. DESIGN: In a double-blind, placebo-controlled trial, 195 subjects were randomly assigned to receive 1000 microg vitamin B-12, 1000 microg vitamin B-12 + 400 microg folic acid, or placebo for 24 wk. Vitamin B-12 status was assessed on the basis of methylmalonic acid, total homocysteine (tHcy), and holotranscobalamin (holoTC) concentrations before and after 12 and 24 wk of treatment. Cognitive function was assessed before and after 24 wk of treatment with the use of an extensive neuropsychologic test battery that included the domains of attention, construction, sensomotor speed, memory, and executive function. RESULTS: Vitamin B-12 status did not change significantly after treatment in the placebo group; however, oral vitamin B-12 supplementation corrected mild vitamin B-12 deficiency. Vitamin B-12 + folic acid supplementation increased red blood cell folate concentrations and decreased tHcy concentrations by 36%. Improvement in memory function was greater in the placebo group than in the group who received vitamin B-12 alone (P = 0.0036). Neither supplementation with vitamin B-12 alone nor that in combination with folic acid was accompanied by any improvement in other cognitive domains. CONCLUSION: Oral supplementation with vitamin B-12 alone or in combination with folic acid for 24 wk does not improve cognitive function. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|